Lal Devyani, Golisch Kimberly B, Elwell Zachary A, Divekar Rohit D, Rank Matthew A, Chang Yu-Hui
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic in Arizona, Phoenix, AZ.
School of Medicine, University of Arizona, Tucson, AZ.
Int Forum Allergy Rhinol. 2016 Sep;6(9):896-905. doi: 10.1002/alr.21773. Epub 2016 Apr 15.
Women electing endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) report higher symptom burden but have lower computed tomography (CT) scores. Gender-specific analysis of outcomes from ESS therefore merits further study. The objective of this work was to study gender-specific differences in outcomes from ESS for CRS by analyzing preoperative and postoperative 22-item Sino-Nasal Outcome Test (SNOT-22) scores.
Data from adult CRS patients electing ESS (2011-2013) were retrospectively collected. SNOT-22 total, rhinologic/nonrhinologic subdomain, and individual item scores were analyzed for gender-specific differences.
Two hundred and forty-eight patients met study criteria (mean age 55.4 years; 49.6% female). Preoperatively, mean Lund-Mackay CT score was 11.1; average total SNOT-22 score was 41.9. Compared to men, women had lower CT score (10.2 vs 12.0; p = 0.004) but higher total SNOT-22 score (44.7 vs 39.1; p = 0.02). Both genders showed significant improvement in total SNOT-22 scores at 3, 6, 12, and 24 months following ESS (p < 0.001), with largely similar slopes of improvement. The greatest improvement occurred at 3 months (SNOT-22 decreased by 25.4 points), with stable improvement after 12 months (SNOT-22 decreased by 21.3 points). Higher total SNOT-22 scores in females were noted preoperatively and until 6 months post-ESS; these were driven by rhinologic and nonrhinologic-otolaryngic subdomain items. No gender differences in anxiety/depression prevalence or psychological subdomain scores were noted preoperatively or postoperatively.
Both male and female CRS patients showed significant and durable symptom relief following ESS. Women reported higher symptom burden prior to surgery, and in the early postoperative period. However, after 1-year post-ESS, both genders showed similar symptom scores. The trend and magnitude of improvement were similar in both genders.
选择接受内镜鼻窦手术(ESS)治疗慢性鼻-鼻窦炎(CRS)的女性报告的症状负担较重,但计算机断层扫描(CT)评分较低。因此,对ESS治疗结果进行性别特异性分析值得进一步研究。本研究的目的是通过分析术前和术后22项鼻-鼻窦结局测试(SNOT-22)评分,研究ESS治疗CRS的性别特异性差异。
回顾性收集2011年至2013年选择接受ESS治疗的成年CRS患者的数据。分析SNOT-22总分、鼻科/非鼻科子域及单项评分的性别特异性差异。
248例患者符合研究标准(平均年龄55.4岁;49.6%为女性)。术前,平均Lund-Mackay CT评分为11.1;SNOT-22平均总评分为41.9。与男性相比,女性CT评分较低(10.2对12.0;p = 0.004),但SNOT-22总评分较高(44.7对39.1;p = 0.02)。ESS术后3、6、12和24个月时,两性的SNOT-22总评分均有显著改善(p < 0.001),改善斜率大致相似。最大改善发生在术后3个月(SNOT-22降低25.4分),12个月后改善稳定(SNOT-22降低21.3分)。术前及ESS术后6个月内,女性的SNOT-22总评分较高;这是由鼻科及非鼻科-耳鼻喉科子域项目所致。术前及术后焦虑/抑郁患病率或心理子域评分均未发现性别差异。
ESS术后,男性和女性CRS患者的症状均得到显著且持久的缓解。女性在手术前及术后早期报告的症状负担较重。然而,ESS术后1年,两性的症状评分相似。两性改善的趋势和幅度相似。